Google TrendSOX SCORE (1000+) — MLB playoffs 2026: Inside White Sox's postseason pitching plan
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Synthetic control arm fro" (30 stories)

Top Headline Story

What Makes the Synthetic Control Design of ARASEC Innovative
Lead StoryUrology Timesgeneral
Jun 4

What Makes the Synthetic Control Design of ARASEC Innovative

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNcUZRZjBXRFhpTk1nOEs2SE5LQ3MwMjlOOU10dmFwb3B3MWlReUhkV2RyX0tZUDVDU2U5UmdWRHgtQzBEN0kzMF8yakd2c25QRnBuS2ttakRPUzNUaTVodndoSXRjUnNVQi1IeGRPUW50UmFuMnZUcERHNURVUm12b3ZOVWloVlFYT01QYkFFeEhNRHFFQlVtSW9B?oc=5" target="_blank">What Makes the Synthetic Control Design of ARASEC Innovative</a>  <font color="#6f6f6f">Urology Times</font>

Real-time search volume
1000+23m ago

sox score

MLB playoffs 2026: Inside White Sox's postseason pitching plan

500+23m ago

bill maher

Michael Douglas Tells Bill Maher About Smuggling Marijuana in Suitcases, Slams ‘Nepo Baby’ Label

500+23m ago

ben simmons

Ben Simmons to make his Kings debut against Golden State

200+23m ago

lisa

Trump Announces White House Inquiry Into Fed Governor Lisa Cook

Search Results for "Synthetic control arm fro"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Peripheral control enabled by distributed sensing in an octopus-inspired soft robotic arm for autonomous underwater grasping
Natureworld

Peripheral control enabled by distributed sensing in an octopus-inspired soft robotic arm for autonomous underwater grasping

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBWWl8wX1VrMGRmbHB2WERmZXNfOENYWnRmVjBsY21VZ2dyTVlveFpMTUtSeUJfS0M3VjJpLTVPZnVNZVNEb3BxWGN2RmY5elgwdEV3b3c4UVlFSmxPSW1B?oc=5" target="_blank">Peripheral control enabled by distributed sensing in an octopus-inspired soft robotic arm for autonomous underwater grasping</a>  <font color="#6f6f6f">Nature</font>

Will synthetic control arms revolutionize clinical trials?
Serviergeneral

Will synthetic control arms revolutionize clinical trials?

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPSGxfay1WN1M1a0dNRTREWVBfeGJCWUVJMmU2NjFSaXp4by0taUJQczBQeTAyNnl0VUtrVlYwVVpQTldCWi03blEyWF9IRXBwYVlueE0wUUVGaXlKNUJiYkVqOG90MjNVcWFkTlp2MUtSajdlVllHdW9sd2RMY1B6eVU1enNmVHV3S241aUpR?oc=5" target="_blank">Will synthetic control arms revolutionize clinical trials?</a>  <font color="#6f6f6f">Servier</font>

The Pros And Cons Of Synthetic Control Arms In Clinical Trials
Clinical Leadergeneral

The Pros And Cons Of Synthetic Control Arms In Clinical Trials

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNTUVuWkxpSklId2ZWd2U5ZUU5SDFMMV82WXFEWThyUlgtYVFSY2Rqb1dVVU84N21XVTJ6SjZzRUJyX1hMTkdhMDZVVEwxNFBlaWxsak1ORzE1U3paQThSdndpcGxuRTE5WXI3aEpGY21nTGROWUFJdTdyVllIdTJEZ3lvdWRKVkduQVRZajFXb05LVVdjODlwZzZJOUpfZkR6b1BHXw?oc=5" target="_blank">The Pros And Cons Of Synthetic Control Arms In Clinical Trials</a>  <font color="#6f6f6f">Clinical Leader</font>

When placebos aren’t an option: synthetic control arms in rare and severe diseases
Drug Discovery Newsgeneral

When placebos aren’t an option: synthetic control arms in rare and severe diseases

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPNnBzLXdfc0VZOVBPUFJJcTBlTXdYOTFIM2NzWk5sTDhRSWxLTjhtQlpCYlVYMFJmRXBnRnVKcUlkVEw3MkN1OXhfeTkxanJhYXJ5bHp6dlpxTWlTSVFfa3JBeDhaUnZtSDZaY0F3S2lNSUgtVWRReWFkVnRwTDNNVktHMW0zTDdxVUx6MGxyR2VVOFh4N0s3V280TXktT2ZNcDRmams3MS1nZFo5aUlCRGwtdnJvSUJzS1BsU0hR?oc=5" target="_blank">When placebos aren’t an option: synthetic control arms in rare and severe diseases</a>  <font color="#6f6f6f">Drug Discovery News</font>

Synthetic control arms can save time and money in clinical trials
STATgeneral

Synthetic control arms can save time and money in clinical trials

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOUzY1TUstU3M2VER5UGlfdDFIYnRhRzlqMHlLbDVRMFlfcmt3aXh4c0t2UXNyVXJ6V0x0MUVzbGp1eG9paHRtVjRVZTNUenZ4eUpzVDZqMmhXOW9wZ29ReGpZNGEyT25vNF82MGZ4ZVJOUTJIZzRCZDA3eWpYMjNjNA?oc=5" target="_blank">Synthetic control arms can save time and money in clinical trials</a>  <font color="#6f6f6f">STAT</font>

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal
Natureworld

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1ZSTNVTjJCVFduenpaNWRvYlJJSzJoRnR1WWFOWWwwclVRdjdZY1J4MGI2SnBpbnpsZ3FIVHBNUlp2VTFGYU5peXdVZEhmQkpUWE5GR3BlcjMyRkx5WElR?oc=5" target="_blank">Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Synthetic control arm: the end of placebos?
AbbViegeneral

Synthetic control arm: the end of placebos?

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQWVB2UFM0YktSQXdPa0hxMzhDN29aSHpLRmdDY0laNi1YV3hVLWtObmFtN0VwZWhxZVJtM3ZFSjVtQXdWR293ejhrVnBSUDg0SUZtdGJneVBreF9ZZFkzTUsyQW5qeU51MjUyODEycTc2NEMtWUNGWXlEQU1lZmE0VXVHRWw0MmwzMm5IdG5B?oc=5" target="_blank">Synthetic control arm: the end of placebos?</a>  <font color="#6f6f6f">AbbVie</font>

Medidata Synthetic Control Arm Supported by the US Food and Drug Administration for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent Glioblastoma
Dassault Systèmesgeneral

Medidata Synthetic Control Arm Supported by the US Food and Drug Administration for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent Glioblastoma

<a href="https://news.google.com/rss/articles/CBMipwJBVV95cUxOcXpDaVpNS04zT1NkYVNIOE5PZkU0TEtLeFhlbTFCU0c0VF9ZWnpEa09pLWpxYmZMZW10VkFfMVhsdGJKakYtSjVIMFJSM3VaZHJrN1BXRElQcmJoUERramhsMU5hVUoxdXlWNlNHTFBjMTZ5RDl0ZnEzeG1oYWxMbnRQSjA3LTJCb2JFWkF2OFZhUDh3SHZIcERqSHVJel92NlRCWS1vNmMwQTlLekxzR2pYU09Sdm1rYUJDNVhDSi1hNEQ0Q1pzY2FhWFRlVXh1ZUpHMDVNWTMwMWVJR3M1enBFYWNSNXFaLXBVSzRSNWVvaVpzOEhwd3dDQUdPYXBSbkRSRmQtYjNadmFXQjVUSW1Id3RnQ1k4ZWo2Xzc2Z1NKS01oeng4?oc=5" target="_blank">Medidata Synthetic Control Arm Supported by the US Food and Drug Administration for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent Glioblastoma</a>  <font color="#6f6f6f">Dassault Systèmes</font>

Synthetic Control Arms: A Broader Clinical reach
PharmaVoicegeneral

Synthetic Control Arms: A Broader Clinical reach

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQQWVEUnM0Y2JCMWRKRjZFeGNXeXkwSFFjZXRHd1d1RGc0bGhvT25JbHEzelJjanZJSWxhN2JZeDgteEJiempXQmZlRFZLWG4zakJiWFBtYlV1T0p4T1hmMjY5RFpVd1h6OUNpanN5QzV1bzRJTW45WXdpRHJxVGxJeTNaVHoyang4ODhwSVRPMHVmMThSV3F1dVZ1Rnk?oc=5" target="_blank">Synthetic Control Arms: A Broader Clinical reach</a>  <font color="#6f6f6f">PharmaVoice</font>

External control arms: when can historical data substitute for placebos?
Clinical Trials Arenageneral

External control arms: when can historical data substitute for placebos?

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBPYUxJVlNjRHUxVm1NRGhQakF1SXFUY0JlaVotMF9MdGtjUTV3bG0wQkxZTTBpZTZGUHJBS0F0aTJSZ0huaHZYNWdmdXFnQWdEZXRYRENreS1DaVM3cmU4ZklhdUFFTHNSMnRuNFFDeWwtcjNFMWc?oc=5" target="_blank">External control arms: when can historical data substitute for placebos?</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Rare Disease Day: Enhancing clinical trial success in rare diseases
pharmaphorumgeneral

Rare Disease Day: Enhancing clinical trial success in rare diseases

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNQUJ5QnVPM3NMRUNFbUduYmZJLXZ3VlZNYzFod0xXWkljandOUldmemdIZlFiTDNtRXE5N2JyZG1OUWl5QXV2QkFFUks0N3ZNWjJ2dk5BeUZ2ODh4Qlc3Z25FS1JseFRTM0VWWl94c1FCLXRwXzQ5dEJZNFptLUJlQnpkX0F2TElvaTZMVmZNUDd5TmVKdVE?oc=5" target="_blank">Rare Disease Day: Enhancing clinical trial success in rare diseases</a>  <font color="#6f6f6f">pharmaphorum</font>

Artificial intelligence in oncology drug development and management: a precision medicine perspective
Frontiersgeneral

Artificial intelligence in oncology drug development and management: a precision medicine perspective

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxORVItWWwtNkxQcV83ank0WC1xWjRmalpid09sM2Y2bUJEeUFhSzZlLXpXRXgzcXlhR2NmSnQ2bjNIaHNna1E0VGpxTFVqMVlJRlpmNjFqbGo3TmlOYlFHNkVjT05FWDdUZ2V0Zy1zakR6QjRmNWtrLVpienZQbmZSUzI3bFVqUDZXMHl2MU1B?oc=5" target="_blank">Artificial intelligence in oncology drug development and management: a precision medicine perspective</a>  <font color="#6f6f6f">Frontiers</font>

Novel clinical trial designs emerging from the molecular reclassification of cancer
Wiley & Sonsgeneral

Novel clinical trial designs emerging from the molecular reclassification of cancer

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9BUHk3MHplcTQtdFNTN1dRZTN4cHZOYktHTVhyVE9OQ2RfSUZNSEp4ZWZId1JDaWNTSm1iV3FHTS05Z3ZmVEZpSFlLS2cwNTE1emxnNXluWEtwRlNtUGNrWmNQQlFhTTdRNURYeEdsektjU3FQ?oc=5" target="_blank">Novel clinical trial designs emerging from the molecular reclassification of cancer</a>  <font color="#6f6f6f">Wiley & Sons</font>

Will Real World Performance Replace RCTs As Healthcare's Most Important Standard?
Forbesscience

Will Real World Performance Replace RCTs As Healthcare's Most Important Standard?

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPN0RyVWtRYzBfTnUzeHYwS2JzcXlqNWhVNHUtV2ZrOWJxV2JiZ2w4eTlpM0ptOEsyQVUwcUVlV2d2Y3ZndGlpRWpvNlZRYXZKZV90NkJTU0QyOHNZRTZPSFFtbktFN3B4SGxqenZCYVoyUGx1a3ZoT19zRGNfMWQ0bXhOOWVvTENqdWxHTUZFa3FvMzJub0RNTklmM2UtNTdOWXFFbW5OMktVTzAycjJqX0VMakpDODF5MUd2TUgzYXg2Z3Y0TmN2UXAwZmR4akU?oc=5" target="_blank">Will Real World Performance Replace RCTs As Healthcare's Most Important Standard?</a>  <font color="#6f6f6f">Forbes</font>

Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors
Naturegeneral

Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE12SUdEWVcyR2M1TnV1bXI5OXItemx3OTBlRHRJRG40M3FFSm4zV2JKSnB0b21lejFxRnhGbDBGaDhfYndocjdCMXllMjU1M3B4UGVzd0hjNmx6OUZqM3dR?oc=5" target="_blank">Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors</a>  <font color="#6f6f6f">Nature</font>

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings
Naturemarkets

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fZzZ0c1ZfanFPUzNsWGpFYVBNZWhQNUV5a3ZqOXJSNEF5amFZWWVTNS1jQllrd04xSG1EVmdjMnJQaWl2Q2lvWFdCMWE0RVlqdExhcDQ0blk2X2M3anZF?oc=5" target="_blank">FedECA: federated external control arms for causal inference with time-to-event data in distributed settings</a>  <font color="#6f6f6f">Nature</font>

Impact of using artificial intelligence as a second reader in breast screening including arbitration
Naturegeneral

Impact of using artificial intelligence as a second reader in breast screening including arbitration

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBsOGdNYXlPLUwwdEZqb0V2b2VFSDlFLWRCYkdGdll1NzNVbS1aMmp1UFB4VTJfLXB4M1YzUG1CNkRlbVdJYnJPTVlfN24wXzNTak9tOGRlSS1uemNET3hn?oc=5" target="_blank">Impact of using artificial intelligence as a second reader in breast screening including arbitration</a>  <font color="#6f6f6f">Nature</font>

A novel cloud-based artificial intelligence for real-time detection of colorectal neoplasia – a randomized controlled trial (EAGLE)
Naturegeneral

A novel cloud-based artificial intelligence for real-time detection of colorectal neoplasia – a randomized controlled trial (EAGLE)

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5jejM3c0hyNG85V3diZUk4bU1yNTk5cW5EMWYtbFhPTkNDRmx6cTdkUS1IbUhyZEM1RERIb0JvLVFRc2RGc3kxcWIyY2FpdXlxZ21LRDF3NDdDWXdpYVA4?oc=5" target="_blank">A novel cloud-based artificial intelligence for real-time detection of colorectal neoplasia – a randomized controlled trial (EAGLE)</a>  <font color="#6f6f6f">Nature</font>

The design and evaluation of hybrid controlled trials that leverage external data and randomization
Naturegeneral

The design and evaluation of hybrid controlled trials that leverage external data and randomization

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5OQ3ZiUmRHZ2dGbVZFUlR2bjFUOHVpSUxQYmZSQWVXYzN4Nl9hNkFMcmxhLXlJVmhILU8tTjVQd25Ha204cG91OG5IVEpmbzJTeWR6cmQxN28weG5vWGFv?oc=5" target="_blank">The design and evaluation of hybrid controlled trials that leverage external data and randomization</a>  <font color="#6f6f6f">Nature</font>

FDA’s New Cell and Gene Therapy Guidances Finally Go a 'Click Further' to 'Game Changing'
BioSpacegeneral

FDA’s New Cell and Gene Therapy Guidances Finally Go a 'Click Further' to 'Game Changing'

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQeVh2VENsaXZiRTRPM3VYYXpFV3d3Skt5eGo5QVJqUUJ5c2tFVTNDWnBqeDViOTVBU3Yxb3JqRFpLeWJybjlVN2JLZi1vWXI3NHlicmd2cW9EOWttWnpvLTNPTFp3eW1rbU83OGJBNzJWOGRmTmRPbUVpNWo4UENidWN2c0NkQ1g1MmZmdFJOU05LNVFDRURpNmlzNk93RVBncktsRkhoWnFKb2hyOV85bzBzTQ?oc=5" target="_blank">FDA’s New Cell and Gene Therapy Guidances Finally Go a 'Click Further' to 'Game Changing'</a>  <font color="#6f6f6f">BioSpace</font>

Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease?
Wiley Online Libraryworld

Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease?

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9JemQ5b2JmTGNqQXBSSm5SbkQ0a2FONVgtSl9laWwtRmhFRlg2alJMVXllSWxQRUFYMGdtTzN2elViVThQMkNNaFZCTWdBbzJSTGQ1N04xYmFNTDQ5Vkg3Tm96M0xQbHgxVWc?oc=5" target="_blank">Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease?</a>  <font color="#6f6f6f">Wiley Online Library</font>

Improving the FITness of colorectal cancer screening
Naturegeneral

Improving the FITness of colorectal cancer screening

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5qalZmR1BGX2RyWndKSTdWVzJKdnZJbDJ2dTJDR2NZX2x1empkNlFUTzNTN296TnB3V1A2UzBzV0RrLXFHYTJvRkJleklIMWh3WFZmdDhlQXRKTU82b2s4?oc=5" target="_blank">Improving the FITness of colorectal cancer screening</a>  <font color="#6f6f6f">Nature</font>

An evaluation of the replicability of analyses using synthetic health data - Scientific Reports
Naturescience

An evaluation of the replicability of analyses using synthetic health data - Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE40dGpkWFE4SEhjdng4eXFsZ3NlZTFIemRSNVJPNDlPRkRDYi1RNFRQQ3BMX20wN0ZDM3FkckJ4MzQ0V19rZWZrMEZCTktvZl9KN2VHNHE1YU5vZzBaMDJV?oc=5" target="_blank">An evaluation of the replicability of analyses using synthetic health data - Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Amputees often feel disconnected from their bionic hands. AI could bridge the gap : Shots - Health News
NPRtech

Amputees often feel disconnected from their bionic hands. AI could bridge the gap : Shots - Health News

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQVHYzaU12ZzVvWkJLMm9QcG5VLUZnSldiRF9jTTMxTldKYXNDUXlJZjdZRVRlZ2czYkJaWHZSLTdOMVlKaDExaE5pck5janZKR2FEbkhoblp2bXg0Nk96N3BvLVlkeko3YkhoNUs3dnFYUkRqZmpfRlVGVHMxbWpZQWIwVzdDdXVISUV3RjduYzlTcnVrdzZxMFBudGtIcGxITi1OSnlXdlpVTThZWmItSFVnVGc0TjFUUGc?oc=5" target="_blank">Amputees often feel disconnected from their bionic hands. AI could bridge the gap : Shots - Health News</a>  <font color="#6f6f6f">NPR</font>

The turbulent AI era is here. The choices we make now are critical.
Gates Notestech

The turbulent AI era is here. The choices we make now are critical.

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQWjJReG5nQkZUUnNySlFzcHE4U2ptdWtZazE0YzZEQzNsVl9nU2VrX1lxYm1ZVFpORFc1VE1GQTFyN1RLaGl2NE52aXZsS1ZETnVtajBhNEk5S2JyOVRLUlJ5UUREMTRkeWZ3TF9XajFuTmNSaEpEd2Qyb2w5bWM4ZWlIRjZRYllUeGNKMGxjTUt5WE12d1FmMW5rSVJtZU5CaHBLNkhIVF9KWXNadWNGZnhn?oc=5" target="_blank">The turbulent AI era is here. The choices we make now are critical.</a>  <font color="#6f6f6f">Gates Notes</font>

An autonomous laboratory for the accelerated synthesis of inorganic materials
Naturegeneral

An autonomous laboratory for the accelerated synthesis of inorganic materials

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9yUTJ0SjRNVXBIVW1ORElqSnpUekRiZzdZSzA0UVVpSDJPQmtZcEhMX3h3X1JyWWZ3aW12dk4tVUFzektCMXhNaUxkTDZNQTlJRUdERFZhZ0lDWG9CWUlj?oc=5" target="_blank">An autonomous laboratory for the accelerated synthesis of inorganic materials</a>  <font color="#6f6f6f">Nature</font>

Celsion’s OVATION 1 Study with GEN-1 in Ovarian Cancer
GlobeNewswiregeneral

Celsion’s OVATION 1 Study with GEN-1 in Ovarian Cancer

<a href="https://news.google.com/rss/articles/CBMixgJBVV95cUxQYmtXSlVyTjV2VWNXZEpSY2tNc3FpSFZndU04dE5NVlduS3o4c19PbXlGOUJ0d2IzRXVzMjFzMXYwTGpWaWUzUU1qd3ZIanpFYUJvbHZ3WWRxZ0NwSnE5Z2NtZ0xVdHRJRnNSMi0xdGRLVTVNMlEtYXZLZncyT2JybGtoTUM4R3Q5NS1mb2RnaGFLR2NHbUpMX2lFLWthRzdKdjNqT3lTTmFqYW1CSUdveWZ5M1FmOG1jS212eFJJNzBSUU9wZnliaWdHV3FseFlHaXhFSVFXQUtSWnRTSVpnai1ObF95RVlfbG5keEQtSVFrc0doMTV5SmZiYWQtRjBTQW9qRjNqWDVIV2N3cDlQREUyX3N5MHhGc2d4dWItZ0xyWHpRclNJblN4OVJZNDdUNkstZkVleUlraFNJOUNZU0JGZWZvUQ?oc=5" target="_blank">Celsion’s OVATION 1 Study with GEN-1 in Ovarian Cancer</a>  <font color="#6f6f6f">GlobeNewswire</font>

A continuous artificial muscle unlocks dexterous soft-robot motion
Tech Xploreworld

A continuous artificial muscle unlocks dexterous soft-robot motion

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxQaldzRExwdjlDTmxVZGE3eWItSXd1OVhoYjJuYXlOZGRBSXdNQTEwYnNsS0RLaHNpbkl3TEY2RWVRNUQ3OGJ0Rmw5QVdlVnJJalBHRnBUYk5kTzNQckFjWllYQ0F4Q2RsTzBXc0hIbDhlNXgxV1VxaXlqS3plYzlWMWNIQWxkUQ?oc=5" target="_blank">A continuous artificial muscle unlocks dexterous soft-robot motion</a>  <font color="#6f6f6f">Tech Xplore</font>

Semiautomated experiment with a robotic system and data generation by foundation models for synthesis of polyamic acid particles
Natureworld

Semiautomated experiment with a robotic system and data generation by foundation models for synthesis of polyamic acid particles

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5jQ2xUUm1BdHhweThZQmZyOWo0dFFOaFJpSnc2SmhNdVVIRWNjS2tsZ0wzYzBfSmJOY1laZ19hb0R4b19lcWtyY056RGYxMUJvbVlJN3V2TnAxOWE1eDRn?oc=5" target="_blank">Semiautomated experiment with a robotic system and data generation by foundation models for synthesis of polyamic acid particles</a>  <font color="#6f6f6f">Nature</font>